Lexeo Therapeutics, Inc. (LXEO) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "LXEO"
      ],
      "issuer_cik": "0001907108",
      "owner_cik": "0001995218",
      "accession_number": "0001995218-26-000009",
      "form_type": "4",
      "filing_date": "2026-04-07",
      "period_of_report": "2026-04-06",
      "issuer_name": "Lexeo Therapeutics, Inc.",
      "issuer_trading_symbol": "LXEO",
      "owner_name": "Townsend Richard Nolan",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Executive Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-04-06",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 55000,
      "transaction_price_per_share": 5.6934,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 340106,
      "transaction_value": 313137,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025."
        },
        {
          "id": "F2",
          "description": "This transaction was executed in multiple trades at prices ranging from $5.56 to $5.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."
        },
        {
          "id": "F3",
          "description": "Includes 261,349 Restricted Stock Units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."
        }
      ]
    }
  ]
}

// trimmed to 1 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.